Table 4.
MDS-CA | ||
---|---|---|
| ||
Variable | P-value | ORa (95% CI) |
Univariate | ||
MDS-CA present at any time before mobilization | < 0.001 | 9.70 (3.78–24.8) |
Prior MDS-CAb | 0.009 | 20.6 (2.06–206) |
Hemoglobin <11 g/dl before mobilization | 0.016 | 2.74 (1.20–6.24) |
Albumin <3.5g/dl | 0.030 | 2.27 (1.11–3.03) |
Poor collection (<2.5 × 106 CD34 + cells/kg) | 0.035 | 2.59 (0.97–6.90) |
CD34 count of initial HPC collection per day | 0.093 | 0.79 (0.60–1.04) |
Multivariate | ||
MDS-CA present at any time before mobilization | < 0.001 | 11.6 (3.17–144) |
Albumin <3.5g/dl | 0.025 | 3.13 (1.09–8.76) |
Clinical MDS/AML | ||
| ||
Univariate | ||
MDS-CA present at any time before mobilization | 0.001 | 5.88 (2.04–12.34) |
Albumin <3.5g/dl | 0.013 | 4.56 (1.30–9.76) |
Bone marrow cellularity<30% | 0.066 | 2.77 (0.89–8.33) |
Beta-2 microglobulin | 0.074 | 1.01 (0.96–1.03) |
CD34 count of initial HPC collection per day | 0.086 | 0.76 (0.58–1.04) |
Multivariate | ||
Albumin <3.5g/dl | 0.058 | 5.18 (0.94–28.4) |
MDS-CA present at any time before mobilization | 0.076 | 3.30 (0.87–12.4) |
Abbreviations: aHCT, autologous hematopoietic progenitor cell transplant; CA, cytogenetic abnormalities; CI, confidence interval; Epo, erythropoietin; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-monocyte colony-stimulating factor; HPC, hematopoietic progenitor cell; MDS, myelodysplastic syndrome; OR, odds ratio; WBC, white blood cells.
The OR of a dichotomous variable for a given event represents the ratio of odds of a certain event happening when comparing the two possible outcomes. For continuous variables, the OR represents the same value for an increase of one unit of that variable. An OR>1 represents a positive correlation of the variable with the effect of interest (higher odds for the event of interest) while an OR<1 represents an adverse one (lower odds for the event of interest).
Within 1-month before mobilization.